Affinia Therapeutics Receives European Medicines Agency Orphan Drug Designation for AFTX-201 in BAG3-Associated Dilated Cardiomyopathy (DCM)
BAG3 DCM is a devastating genetic heart disease caused by a mutation in the BAG3 gene and resulting in loss of heart function at a young age; despite current standard... Read more.
Sharon AI Announces Nasdaq Listing and Pricing of $125 Million U.S. Initial Public Offering
NEW YORK–(BUSINESS WIRE)–SharonAI Holdings Inc. and its subsidiaries (“Sharon AI” or the “Company”), a leading Australian Neocloud, today announced... Read more.
Delta Galil Reports Fourth Quarter and Full Year 2025 Results
Record Fourth Quarter and Full Year Sales Record Fourth Quarter Direct-To-Consumer Sales Record Fourth Quarter Gross Profit Expanded 5% to $263.2 Million Strong... Read more.
Zywave Unveils Winter 2026 Release to Help Brokers Win More Deals Faster
Four new AI agents combined with other technology advancements significantly streamline workflows, empowering producers to focus on driving revenue, not admin tasks... Read more.
Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK... Read more.
Starlab Space Announces Partnership with Helogen to Advance Life Sciences Research in Microgravity
The Helogen HEL-IOS™ orbital biomedical operating system will be integrated in the Starlab space station to enable continuous, autonomous biological discovery... Read more.
INVESTOR DEADLINE: Enphase Energy, Inc. (ENPH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
SAN DIEGO–(BUSINESS WIRE)–$ENPH #ENPH–The law firm of Robbins Geller Rudman & Dowd LLP announces that the Enphase Energy class action lawsuit... Read more.
NeoGenomics to Participate in Upcoming Investor Conferences
FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine,... Read more.
AcuityMD Announces AcuityMD for Salesforce on Salesforce AppExchange
AcuityMD’s customers can now benefit from a Salesforce integration that unifies market intelligence and rep-centric workflows BOSTON–(BUSINESS WIRE)–#MedTech–AcuityMD... Read more.
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative... Read more.